Literature DB >> 19460650

Chemical restraint, anesthesia, and analgesia for camelids.

Eric J Abrahamsen1.   

Abstract

This article covers techniques used to provide chemical restraint, injectable or inhalation anesthesia, and analgesia in camelid patients. Understanding the information presented improves safety and efficacy when using the techniques presented in the article. This article focuses primarily on llama and alpaca patients. Of the techniques that have been used on camels, the dosing protocols provided have proven effective.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19460650     DOI: 10.1016/j.cvfa.2009.02.001

Source DB:  PubMed          Journal:  Vet Clin North Am Food Anim Pract        ISSN: 0749-0720            Impact factor:   3.357


  5 in total

1.  Comparison of invasive and oscillometric blood pressure measurement techniques in anesthetized camelids.

Authors:  Turi K Aarnes; John A E Hubbell; Phillip Lerche; Richard M Bednarski
Journal:  Can Vet J       Date:  2012-08       Impact factor: 1.008

2.  Surgical replacement of iatrogenically prolapsed penis in a dromedary camel.

Authors:  M I Siddiqui; M N Telfah; S A T Al-Qubati
Journal:  Open Vet J       Date:  2012-11-28

3.  Ultrasound-guided psoas compartment and sciatic nerve blocks for pain management of hind limb procedures in the alpaca (Vicugna pacos).

Authors:  Andrew Foster; Alex McSloy; Paolo Monticelli
Journal:  Open Vet J       Date:  2020-04-07

4.  Sedative, analgesic, behavioral and clinical effects of intravenous nalbuphine-xylazine combination in camels (Camelus dromedarius).

Authors:  Ahmed H Khalil; Atef S Abd Al-Galil; Ahmed A Sabek; Mohamed M Zeineldin; Seham Y Abo-Kora
Journal:  J Vet Sci       Date:  2019-09       Impact factor: 1.672

5.  Magnetic resonance imaging of the normal dromedary camel tarsus.

Authors:  Zakriya Ali Al Mohamad; Usama Hagag; Mohamed Gomaa Tawfiek; Ayman El Nahas
Journal:  BMC Vet Res       Date:  2021-03-02       Impact factor: 2.741

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.